Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland. Show more
401 Professional Drive, Gaithersburg, MD, 20879, United States
Market Cap
3.723M
52 Wk Range
$0.50 - $6.20
Previous Close
$0.64
Open
$0.66
Volume
459,703
Day Range
$0.64 - $0.70
Enterprise Value
3.699M
Cash
334K
Avg Qtr Burn
-973K
Insider Ownership
0.94%
Institutional Own.
3.85%
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|